A bill to amend title XIX of the Social Security Act to require coverage under State plans under the Medicaid program for annual lung cancer screening with no cost sharing for individuals for whom screening is recommended by U.S. Preventive Services Task Force guidelines, to expand coverage under Medicaid of counseling and pharmacotherapy for cessation of tobacco use, and for other purposes.

Summary of Bill: S. 4566 (119th Congress)

Purpose and intent

• S. 4566 seeks to amend title XIX of the Social Security Act to strengthen Medicaid coverage related to tobacco use prevention and lung cancer screening.
• The core aims are to:
  • Ensure Medicaid State plans cover annual lung cancer screening with no cost sharing for individuals for whom screening is recommended by U.S. Preventive Services Task Force (USPSTF) guidelines.
  • Expand Medicaid coverage of counseling and pharmacotherapy for tobacco cessation.
  • Address additional related purposes as determined appropriate by the bill.

Key provisions and changes

1. Lung cancer screening with no cost sharing

   • Requires Medicaid state plans under the Medicaid program to cover annual lung cancer screening.
   • Applies to individuals for whom screening is recommended by USPSTF guidelines.
   • Specifies that there would be no cost sharing (no out-of-pocket costs such as copays, deductibles, or coinsurance) for eligible individuals.

2. Tobacco cessation counseling and pharmacotherapy

   • Expands Medicaid coverage to include counseling for tobacco cessation.
   • Expands coverage for pharmacotherapy (medications used to aid quitting tobacco use). This may include items such as nicotine replacement therapy and prescription cessation medications, consistent with evidence-based guidelines.

3. Other purposes

   • The bill contemplates additional purposes related to tobacco use prevention, cessation, and lung cancer screening, as may be specified in the bill’s text.

Who would be affected

• Medicaid beneficiaries who are eligible for USPSTF-recommended annual lung cancer screening:
  • Would receive screening with no cost sharing in states that adopt the mandated coverage.
• Individuals seeking tobacco cessation support:
  • Would have expanded access to counseling and cessation pharmacotherapy under Medicaid.
• State Medicaid programs:
  • States would need to adjust their Medicaid state plan to incorporate the no-cost-sharing lung cancer screening coverage and expanded cessation services.
• Healthcare providers and screening programs:
  • May experience increased demand for USPSTF-guided screening due to removed cost barriers.
  • Depend on approved Medicaid coverage for reimbursement of cessation counseling and medications.

Procedural and timeline aspects

• Introduced and referred: The bill was introduced in the Senate and referred to the Committee on Finance on May 19, 2026.
• Action history to date: Read twice and referred to the Finance Committee (standard step before potential committee consideration and potential floor action).
• Next steps (if progressed):
  • The Finance Committee would review, possibly amend, and vote to report the bill to the Senate floor.
  • If reported, the full Senate would consider the bill; passage would typically lead to conference with the House if there are House counterparts or separate House action.
• Effective date and implementation: The text provided does not specify an effective date. In typical legislation, effective dates are defined within the bill (e.g., upon enactment or a specified future date) and may require regulatory rulemaking by the Centers for Medicare & Medicaid Services (CMS) to implement state plan changes.

Potential impact considerations

• Access and affordability: By eliminating cost sharing for USPSTF-recommended lung cancer screening and expanding cessation services, the bill could reduce financial barriers to preventive care and cessation support for Medicaid beneficiaries.
• Public health outcomes: Potential to improve early detection of lung cancer and increase smoking cessation rates among low-income populations, which may lead to long-term healthcare savings and improved health outcomes.
• State plan adjustments: States would need to modify their Medicaid plans to comply with the new coverage requirements, potentially affecting budgets and administrative processes.
• Policy alignment: Aligns Medicaid coverage with USPSTF guidelines and contemporary tobacco prevention/cessation best practices.

If you’d like, I can compare this bill to existing federal Medicaid authorities or summarize potential fiscal implications once the Congressional Budget Office (CBO) or sponsor analyses are available.